FindTrial
Sign In

Effect of Some Drugs on Rheumatoid Arithritis Activity

Clinical Study Evaluating the Effect of Histamine 1 Receptor Antagonist and Leukotreine Receptor Antagonist on Patients With Rheumatoid Arithritis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03770923
Enrollment
75
Registered
2018-12-10
Start date
2018-10-01
Completion date
2027-10-31
Last updated
2018-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Brief summary

Effect of Some Drugs on Rheumatoid Arithritis Activity.

Detailed description

The study aims at evaluating the effect of Some Drugs on Rheumatoid Arithritis Activity.

Interventions

DRUGRupatadine

Rupatadine 10 mg daily

DRUGMontelukast

Montelukast 10 mg daily

Sponsors

Sherief Abd-Elsalam
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Rheumatoid arthritis

Exclusion criteria

* liver or renal disease

Design outcomes

Primary

MeasureTime frameDescription
se level of IL-176 monthschange in level of IL-17

Countries

Egypt

Contacts

Primary ContactSherief Abd-Elsalam, Ph D
sheriefabdelsalam@yahoo.com00201147773440

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026